Patents by Inventor Duncan John Stewart

Duncan John Stewart has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11654162
    Abstract: Cell based therapy comprises administration to the lung by injection into the blood system of viable, mammalian cells effective for alleviating or inhibiting pulmonary disorders. The cells may express a therapeutic transgene or the cells may be therapeutic in their own right by inducing regenerative effects.
    Type: Grant
    Filed: September 21, 2020
    Date of Patent: May 23, 2023
    Assignee: NORTHERN THERAPEUTICS, INC.
    Inventor: Duncan John Stewart
  • Publication number: 20210145894
    Abstract: Cell based therapy comprises administration to the lung by injection into the blood system of viable, mammalian cells effective for alleviating or inhibiting pulmonary disorders. The cells may express a therapeutic transgene or the cells may be therapeutic in their own right by inducing regenerative effects.
    Type: Application
    Filed: September 21, 2020
    Publication date: May 20, 2021
    Applicant: NORTHERN THERAPEUTICS, INC.
    Inventor: DUNCAN JOHN STEWART
  • Patent number: 10828336
    Abstract: Cell based therapy comprises administration to the lung by injection into the blood system of viable, mammalian cells effective for alleviating or inhibiting pulmonary disorders. The cells may express a therapeutic transgene or the cells may be therapeutic in their own right by inducing regenerative effects.
    Type: Grant
    Filed: February 27, 2017
    Date of Patent: November 10, 2020
    Assignee: Northern Therapeutics Inc.
    Inventor: Duncan John Stewart
  • Patent number: 10660922
    Abstract: Cell based therapy comprises administration to the lung by injection into the blood system of viable, mammalian cells effective for alleviating or inhibiting pulmonary disorders. The cells may express a therapeutic transgene or the cells may be therapeutic in their own right by inducing regenerative effects.
    Type: Grant
    Filed: November 8, 2017
    Date of Patent: May 26, 2020
    Assignee: Northern Therapeutics Inc.
    Inventor: Duncan John Stewart
  • Publication number: 20180333438
    Abstract: Cell based therapy comprises administration to the lung by injection into the blood system of viable, mammalian cells effective for alleviating or inhibiting pulmonary disorders. The cells may express a therapeutic transgene or the cells may be therapeutic in their own right by inducing regenerative effects.
    Type: Application
    Filed: November 8, 2017
    Publication date: November 22, 2018
    Applicant: Northern Therapeutics Inc.
    Inventor: Duncan John Stewart
  • Patent number: 9827270
    Abstract: Cell based therapy comprises administration to the lung by injection into the blood system of viable, mammalian cells effective for alleviating or inhibiting pulmonary disorders. The cells may express a therapeutic transgene or the cells may be therapeutic in their own right by inducing regenerative effects.
    Type: Grant
    Filed: June 13, 2014
    Date of Patent: November 28, 2017
    Assignee: Northern Therapeutics, Inc.
    Inventor: Duncan John Stewart
  • Publication number: 20170312317
    Abstract: Cell based therapy comprises administration to the lung by injection into the blood system of viable, mammalian cells effective for alleviating or inhibiting pulmonary disorders. The cells may express a therapeutic transgene or the cells may be therapeutic in their own right by inducing regenerative effects.
    Type: Application
    Filed: February 27, 2017
    Publication date: November 2, 2017
    Applicant: Northern Therapeutics Inc.
    Inventor: Duncan John Stewart
  • Patent number: 9585916
    Abstract: Cell based therapy comprises administration to the lung by injection into the blood system of viable, mammalian cells effective for alleviating or inhibiting pulmonary disorders. The cells may express a therapeutic transgene or the cells may be therapeutic in their own right by inducing regenerative effects.
    Type: Grant
    Filed: April 3, 2007
    Date of Patent: March 7, 2017
    Assignee: Northern Therapeutics Inc.
    Inventor: Duncan John Stewart
  • Publication number: 20140348806
    Abstract: Cell based therapy comprises administration to the lung by injection into the blood system of viable, mammalian cells effective for alleviating or inhibiting pulmonary disorders. The cells may express a therapeutic transgene or the cells may be therapeutic in their own right by inducing regenerative effects.
    Type: Application
    Filed: June 13, 2014
    Publication date: November 27, 2014
    Applicant: Northern Therapeutics, Inc.
    Inventor: Duncan John Stewart
  • Publication number: 20140328810
    Abstract: Cell based therapy comprises administration to the lung by injection into the blood system of viable, mammalian cells effective for alleviating or inhibiting pulmonary disorders. The cells may express a therapeutic transgene or the cells may be therapeutic in their own right by inducing regenerative effects.
    Type: Application
    Filed: September 18, 2013
    Publication date: November 6, 2014
    Applicant: Northern Therapeutics, Inc.
    Inventor: Duncan John Stewart
  • Patent number: 6592864
    Abstract: Cell-based gene transfer is effected by administering transfected cells containing an expressible transgene into the pulmonary system of a patient, where the cells express and secrete expression products of the transgene directly into the pulmonary system. Also provided is the use of angiogenic factors in treatment of pulmonary hypertension.
    Type: Grant
    Filed: March 26, 1999
    Date of Patent: July 15, 2003
    Inventor: Duncan John Stewart
  • Publication number: 20030118567
    Abstract: Cell based therapy comprises administration to the lung by injection into the blood system of viable, mammalian cells effective for alleviating or inhibiting the disorder. The cells may express a therapeutic transgene or the cells may be regenerative.
    Type: Application
    Filed: September 9, 2002
    Publication date: June 26, 2003
    Inventor: Duncan John Stewart
  • Patent number: 6004295
    Abstract: A catheter assembly especially adapted for injecting therapeutic liquids such as DNA solutions to a patient's myocardium comprises an elongated guiding catheter for insertion through a patient's artery to the vicinity of the myocardium, a reservoir for therapeutic liquid at the distal end of the guiding catheter, one or more injection needles protruding from the distal end of the guiding catheter and in fluid communication with the reservoir, the extent of needle protrusion being appropriate for penetration of but not passage through the myocardial wall, and an operating device for delivering a predetermined quantity of therapeutic liquid from the reservoir through the needles.
    Type: Grant
    Filed: June 26, 1998
    Date of Patent: December 21, 1999
    Assignee: AN-GO-GEN Inc.
    Inventors: Anatoly Langer, Duncan John Stewart